¥46.16
¥0.00 (0.00%)
End-of-day quote: 05/03/2024
SHSE:600276

Jiangsu Hengrui Medicine Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Rev. Revenue
¥22.82B ¥21.28B ¥25.91B ¥27.73B ¥23.29B ¥17.42B ¥13.84B ¥11.09B ¥9.32B ¥7.45B ¥6.20B ¥5.44B ¥4.55B ¥3.74B ¥3.03B ¥2.39B ¥1.98B ¥1.44B ¥1.18B
GM % Gross Margin %
84.39% 83.53% 85.50% 87.90% 87.47% 86.58% 86.62% 87.09% 85.27% 82.35% 81.32% 83.94% 82.73% 82.95% 82.71% 83.25% 83.28% 80.55% 80.50%
OM Operating Margin
18.30% 14.17% 14.58% 22.61% 23.62% 23.31% 25.84% 25.63% 25.90% 22.70% 22.99% 23.62% 22.35% 22.26% 22.73% 25.65% 18.49% 18.87% 19.15%
EPS Earnings Per Share
¥0.00 ¥0.65 ¥0.54 ¥0.66 ¥0.93 ¥0.78 ¥0.60 ¥0.49 ¥0.41 ¥0.34 ¥0.24 ¥0.19 ¥0.17 ¥0.13 ¥0.11 ¥0.09 ¥0.09 ¥0.07 ¥0.03 ¥0.02
Div. Dividends
¥0.20 ¥0.16 ¥0.16 ¥0.17 ¥0.16 ¥0.13 ¥0.06 ¥0.05 ¥0.03 ¥0.02 ¥0.02 ¥0.02 ¥0.02 ¥0.01 ¥0.01 ¥0.01 ¥0.01 ¥0.01 ¥0.00
PR % Payout Ratio %
30.77% 29.63% 24.24% 18.28% 20.51% 21.67% 12.24% 12.20% 8.82% 8.33% 10.53% 11.76% 15.38% 9.09% 11.11% 11.11% 14.29% 33.33% 0
Sha. Shares
6360.56m 6,367m 6381.84m 6354.89m 6341.64m 6327.85m 6326.56m 6316.23m 6305.1m 6292.09m 6292.09m 6292.09m 6292.09m 6292.09m 6253.97m 6253.97m 6253.97m 6253.97m 6253.97m
OCF Operating Cash Flow
¥7.64B ¥1.27B ¥4.22B ¥3.43B ¥3.82B ¥2.77B ¥2.55B ¥2.59B ¥2.28B ¥1.57B ¥1.36B ¥958.37M ¥527.36M ¥385.95M ¥439.12M ¥117.46M ¥210.16M ¥266.18M ¥227.88M
FCF Free Cash Flow
¥5.50B ¥-706.70M ¥2.57B ¥2.88B ¥3.26B ¥2.25B ¥2.17B ¥1.48B ¥1.88B ¥1.28B ¥912.26M ¥491.54M ¥-12.91M ¥99.22M ¥297.47M ¥6.25M ¥143.31M ¥179.89M ¥164.81M
FCFS Free Cash Flow Per Share
¥0.97 ¥-0.11 ¥0.40 ¥0.45 ¥0.51 ¥0.35 ¥0.34 ¥0.23 ¥0.30 ¥0.20 ¥0.14 ¥0.08 ¥-0.00 ¥0.02 ¥0.05 ¥0.00 ¥0.02 ¥0.03 ¥0.03